English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Dec 2, 2025

American Lung Association calls for widespread flu vaccination after severe 2024–25 season

Patient Daily | Dec 2, 2025

Experts question FDA official's claims linking child deaths to COVID-19 vaccines

Patient Daily | Dec 2, 2025

FDA drug center head Richard Pazdur announces retirement after brief tenure

Patient Daily | Dec 2, 2025

Roche announces promising interim results for new Alzheimer’s antibody trontinemab

Patient Daily | Dec 1, 2025

PhRMA Senior Director on 340B abuse: 'If Congress is serious about lowering drug costs, they must reform 340B'

Patient Daily | Dec 1, 2025

Six companies continue work on cell therapy despite recent industry exits

Patient Daily | Dec 1, 2025

New hereditary angioedema treatments expand options but patient switching remains limited

Patient Daily | Dec 1, 2025

Health organizations urge annual flu shots amid high-severity season

Trending

+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal

+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug

  • « First
  • «
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily